EtO Regulations Under Review: Impact on Medical Device Sterilization and Public Safety

The EPA plans to relax emissions restrictions on ethylene oxide, a key sterilization chemical for medical devices, sparking debate over public health risks versus supply chain stability.

Key Highlights

  • Ethylene oxide is essential for sterilizing complex, heat-sensitive medical devices like catheters and surgical kits.
  • The EPA's proposed easing of emissions limits aims to prevent supply disruptions but raises public health concerns due to EtO's carcinogenic nature.
  • Past stricter regulations led to temporary sterilization facility closures, impacting medical device availability.

The U.S. Environmental Protection Agency (EPA) is proposing to ease emissions limits on ethylene oxide (EtO), a move that highlights a growing tension at the heart of healthcare supply chain resilience.

EtO is used to sterilize roughly half of all medical devices in the U.S., including catheters, surgical kits, and implantable products. Its ability to penetrate complex packaging and sterilize heat-sensitive materials makes it indispensable to modern medical manufacturing.

The proposal would roll back elements of stricter Biden-era regulations designed to significantly reduce emissions of the chemical, which is classified as a carcinogen linked to cancers such as lymphoma and leukemia. Federal regulators say the change is intended to avoid unintended consequences, particularly disruptions to the availability of essential medical devices.

Past efforts to tighten EtO controls have already led to temporary sterilization facility closures, raising concerns about supply continuity. Industry stakeholders warn that overly restrictive rules could further constrain capacity, slow production, and limit access to critical products.

Environmental and public health advocates, however, argue that easing standards could increase long-term exposure risks for workers and surrounding communities. The issue highlights a fundamental policy crossroads: how to maintain a reliable supply of sterile medical devices while addressing legitimate public health concerns.

Why It Matters

EtO remains the primary method for sterilizing complex, heat-sensitive medical devices. That makes sterilization a critical, and vulnerable, link in the supply chain.

The broader takeaway is that healthcare supply chain resilience isn't just about efficiency or cost. It increasingly requires balancing competing risks across clinical care, financial performance, and public health.

About the Author

Daniel Beaird

Daniel Beaird

Head of Content and Editor-in-Chief

Daniel Beaird is Head of Content and Editor-in-Chief of Healthcare Purchasing News (HPN), where he leads editorial strategy and content development across print, digital, podcasts, webinars, and educational programming. His coverage focuses on healthcare supply chain, sterile processing, infection prevention, and perioperative services, connecting industry developments with the purchasing and operational decisions that shape patient care. 

Before joining HPN, he served as Senior Editor of The Journal of Healthcare Contracting, covering health system supply chain strategy, industry partnerships and the evolving business of healthcare. 

He holds a bachelor’s degree in journalism from the University of Georgia and is based in Atlanta. 

Sign up for our eNewsletters
Get the latest news and updates